Table 3.
Variable | Not Enrolled | Studies With Postlytic Enrollment | Studies With Prelytic Enrollment | P Value |
---|---|---|---|---|
(N=225) | 46/65 (70.8%) | 19/65 (29.2%) | ||
Onset-to-arrival, median (range) | 66 (17–137) | 60 (25–120) | 59 (15–116) | NS |
Onset-to-treatment, median (range) | 135 (64–180) | 126 (64–180) | 128 (92–178) | NS |
Arrival-to-treatment, median (range) | 62 (20–131) | 59 (23–135) | 72 (52–111) | 0.027* |
0.56† | ||||
0.028‡ |
Comparison of nonenrolled patients with patients that were enrolled in prelytic studies.
Comparison of nonenrolled patients with patients that were enrolled in postlytic studies.
Comparison of patients enrolled in pre- versus postlytic studies.
NS indicates nonsignificant.